Datascope brings Anestar production to US:
This article was originally published in Clinica
Executive Summary
Datascope is shifting production of its Anestar and Anestar S anaesthesia delivery systems from Germany to its facility in New Jersey, having bought the manufacturing rights to the devices from its OEM partner. The move will enable the company to enhance its line of anaesthesia systems without the restrictions of an OEM agreement as well as giving it a competitive boost in the anaesthesia delivery and OR (operating room) patient monitor markets. Datascope, of Montvale, New Jersey, estimates that these two markets together generate $700m in annual worldwide sales.
You may also be interested in...
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.